 |
|
|
|
|
|
|
| Article 1 to 10 out of 27 concerning Abbott Laboratories
|
-
Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
(14 Oct 2008)
Abbott announced the opening of new development laboratories and a pilot plant facility that will research technologies and test large-scale production of newly developed drug formulations. The expansion is part of Abbott's global drug delivery ...
-
Scandal in the Pharmaceutical World
(30 Jun 2008)
A large number of the world's largest pharmaceutical companies have illegally used, and profited from, a groundbreaking patent stolen from Nogdan Immunochemicals Ltd., an Israeli biotech company
Nogdan Immunochemicals Ltd.and Mr. Roland Taieb, the exclusive owner of the patent's marketing rights worldwide, announced that many of the world's largest pharmaceutical companies are embroiled in the legal dispute concerning their groundbreaking ...
-
Abbott's Acquisition of Kos Pharmaceuticals, Inc. Clears Antitrust Review
(06 Dec 2006)
Abbott announced that the Federal Trade Commission has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 applicable to Abbott's offer to purchase all of the outstanding shares of common ...
-
Abbott to Invest S$450 Million (US$280 Million) in Largest Nutritional Plant in Singapore
(24 Apr 2006)
State-of-the-Art Manufacturing Facility to Support Rapidly Growing Demand for Abbott Nutritional Products in Asia
Abbott announced that it is building a nutritional powder manufacturing plant in Singapore's Tuas Biomedical Park 2 at the westernmost tip of the island. The plant is Abbott's first major capital investment in Asia and its largest nutritional ...
-
Tripos Announces Collaboration With Abbott for Chemical Design And Synthesis
(22 Mar 2006)
Tripos, Inc. announced a chemistry collaboration with Abbott to design, synthesize and purify high-quality, novel, drug-like compounds to expand Abbott's compound file collection. Tripos and Abbott will collaborate in library design, analysis and ...
-
New Real-Time PCR Test for Chlamydia and Gonorrhea Receives CE Mark Certification
(25 Jan 2006)
Abbott announced that a highly sensitive new test for the simultaneous detection of the sexually transmitted pathogens Chlamydia trachomatis (CT) and Neissera gonorrhoeae (NG) has received CE Mark certification, allowing it to be marketed in the ...
-
Eisai Submits New Drug Application for Rheumatoid Arthritis Drug Adalimumab (D2E7)
(27 Dec 2005)
Eisai Co., Ltd and Abbott Japan Co., Ltd submitted a new drug application (NDA) to the Minister of Health Labour and Welfare (MHLW) for the manufacturing and marketing for the rheumatoid arthritis drug adalimumab (D2E7), which is co-developed by the ...
-
Abbott named on Top 10 "Best places to work for scientists" by the Scientist Magazine
(16 Jun 2005)
Abbott was recognized this month for its ability to nurture an environment where scientific talent can flourish by being named No. 8 to The Scientist magazine's "Top 10 Best Places to Work for Scientists" list for the second consecutive year. Abbott ...
-
Abbott enters into agreement with Inpeco to expand laboratory automation capabilites
(04 Mar 2005)
Abbott announced that it has entered into an agreement with Inpeco S.p.A. to expand its laboratory automation capabilities. Through the agreement, Abbott plans to offer a suite of automation solutions that can be customized to address key needs ...
-
Abbot Laboratories donates plant to Scotland Development Corporation
(28 Jun 2002)
Laurinburg, North Carolina, June 27, 2002 — Abbott Laboratories announced that it is donating its Laurinburg, North Carolina plant to the Scotland Development Corporation, a non-profit company that seeks employment opportunities to improve the ...
|
|
|
|
|
Top